Latest publications
Valsecchi A. A., Giovanardi F., MALANDRINI F., MEREGAGLIA M., Servetto A., Bennati C., Pinto C., Di Maio M., CIANI O.
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project
The Breast, 2024, vol.78, pp.103817
MALANDRINI F., MEREGAGLIA M., Di Maio M., Pinto C., De Lorenzo F., CIANI O.
The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project
European Journal of Cancer, 2024, vol.207, pp.114161
ARMENI P., CALLEA G., COSTA F., MALANDRINI F., OTTO M., SEGANTIN G., SIRENA P., TARRICONE R.
Il payback come misura di contenimento della spesa per farmaci e dispositivi medici in Rapporto OASI 2023
CERGAS (Eds),Egea, chap. 17, pp.651-698, 2023
ARMENI P., COSTA F., JOMMI C., MALANDRINI F., OTTO M., TARANTOLA A.
L’evoluzione del finanziamento dei farmaci in Italia in Rapporto OASI 2023
CERGAS (Eds),Egea, chap. 8, pp.317-354, 2023
MEREGAGLIA M., MALANDRINI F., Angelini S., CIANI O.
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022
Applied Health Economics and Health Policy, 2023, no. 21, pp.925-935
TARANTOLA A., OTTO M., ARMENI P., COSTA F., MALANDRINI F., JOMMI C.
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
Journal of Pharmaceutical Policy and Practice, 2023, vol.16, no. 1, pp.67